)
)
Infinity Pharmaceuticals Investor Relations Material
Latest events
Investor Update
Infinity Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Infinity Pharmaceuticals Inc
Access all reports
Infinity Pharmaceuticals, Inc. is a biopharmaceutical company which focuses on developing novel medicines for people with cancer. The Company's pipeline includes DVC-1201, an anti-CD20 monoclonal antibody for the treatment of B-cell lymphoma and follicular lymphoma; DVC-1202, an anti-IGF-1R monoclonal antibody for the treatment of colorectal cancer; and is also developing an oral pan-Immunoglobulin product candidate that targets certain cancers
Latest articles
)
Cristiano Amon: Qualcomm's 5G Specialist CEO
Cristiano Amon, Qualcomm CEO, has spent two decades at the company while taking on several roles, developing both technical and business expertise.
16 Sep 2024
)
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Ticker symbol
INFI
Country
🇺🇸 United States